Sinofn Health
Sinofn Health
In the current global nutraceutical landscape, the demand for transparency and E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) has reached an inflection point. SINOFN is not merely an OEM manufacturer; we act as a strategic partner at the intersection of clinical research and consumer wellness.
The nutraceutical industry is pivoting from mass-market products to hyper-personalized solutions. Consumers are increasingly educated about bioavailability, ingredient synergy, and clean-label compliance. At SINOFN, our "Science-Driven OEM" model addresses this by utilizing our Chinese Academy of Sciences (CAS) background to bridge the gap between bench-top clinical research and scalable industrial production.
Global brands are seeking supply chain resilience. They require partners who can offer:
SINOFN provides comprehensive solutions that mitigate risks in international procurement by ensuring strictly audited production environments and blockchain-backed batch tracking.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. We operate as the global hub for premium, science-driven contract manufacturing.
Founded on clinical insight, Mrs. Liu witnessed the struggles of patients with PKU (Phenylketonuria). This inspired the founding of SINOFN in 2012. Her leadership transformed a niche specialized-diet manufacturer into a global player in FSMP (Foods for Special Medical Purposes) and clinical nutraceuticals, ensuring that "profit with purpose" remains at the core of our operations.
Innovation is the DNA of SINOFN. Our R&D team is structured to tackle complex formulation challenges.
Medical Innovation Director, Ph.D. Peking University. 15+ years of experience in metabolic disorder formulations.
R&D Lead, Associate Researcher at Chinese Academy of Sciences. Specialist in bioactive delivery systems.
Formulation Director (Netherlands). Senior scientist focusing on EU regulatory alignment and nutraceutical delivery technology.
Our facility is designed for scalability and safety. With ISO 22000, HACCP, and FSSC 22000 certifications, we ensure that every batch meets rigorous international standards.
As we look toward 2030, SINOFN is investing heavily in:
Our main production bases are strategically located in China, serving global markets with high-level logistics and regulatory support.
Absolutely. We offer pilot-scale runs specifically designed to test efficacy and market viability before full-scale production.
Yes. We provide tailored solutions ranging from small-batch testing for startups to large-scale volume manufacturing for multinational enterprises.
